Dr. Charlie Strange is a professor of pulmonary and critical care medicine at MUSC, with faculty appointments in the Department of Medicine and the Department of Graduate Studies. His clinical interests include chronic obstructive pulmonary disease (with specialty interest in alpha-1 antitrypsin deficiency and bronchoscopic lung volume reduction) and interstitial lung disease (with specialty interest in the connective tissue diseases).
Dr. Strange has interest in rare lung diseases and participates in NIH programs to advance their treatment. He is the principal investigator for the Alpha-1 Foundation Research Registry, the largest registry of individuals with alpha-1 antitrypsin deficiency or the carrier state in the world. The registry is used to support research on new therapies, genetic linkage studies, and social sciences research. The Alpha Coded Testing (ACT) study provides confidential testing for alpha-1 antitrypsin deficiency.
Dr. Strange is available for physician consultations on the above research studies and continues active inpatient and outpatient clinical service. For this activity and teaching, he has been listed in Best Doctors in America 2003 to 2015 for general pulmonary and critical care medicine, interstitial lung diseases, and chronic obstructive pulmonary disease.